BG levels could be finely controlled by insulin, and the abnormal concentration of BG is caused by the absence of insulin secretion (type I diabetes, T1D) or defective insulin secretion and action (type II diabetes, T2D). This evidence concerns the gene INS and type 1 diabetes mellitus.